Improving pharmaceutical protein production in Oryza sativa

Area of Science:

• Biotechnology and Molecular Biology
• Plant Molecular Farming
• Recombinant Protein Production

Background:

• Plant expression systems provide advantages like low cost, safety from human pathogens, and complex glycosylation.
• Rice (Oryza sativa) is a promising platform for producing recombinant proteins, including cytokines, vaccines, and antibodies.
• Transgenic rice cells can be regenerated into plants or cultured in bioreactors for scalable production.

Purpose of the Study:

• To review recent advancements in producing diverse recombinant proteins using rice as an expression system.
• To detail current production methodologies and strategies for improving protein yield and quality in rice.
• To discuss glycosylation in plants and propose novel methods for enhancing rice-based protein production.

Main Methods:

• Review of literature on recombinant protein production in rice.
• Analysis of transformation, regeneration, and cell culture techniques for transgenic rice.
• Exploration of bioreactor options for upscaling plant cell cultures.

Main Results:

• Rice has demonstrated successful production of various recombinant proteins.
• Methods for improving protein yield and quality, including glycosylation engineering, are discussed.
• Different bioreactor systems suitable for rice cell cultures are evaluated.

Conclusions:

• Rice is a viable and advantageous plant expression system for recombinant protein manufacturing.
• Further research into glycosylation and bioreactor optimization can enhance rice's potential.
• This review provides insights into optimizing rice-based molecular farming for therapeutic proteins and vaccines.